JPH11513891A - 細胞系 - Google Patents
細胞系Info
- Publication number
- JPH11513891A JPH11513891A JP9541426A JP54142697A JPH11513891A JP H11513891 A JPH11513891 A JP H11513891A JP 9541426 A JP9541426 A JP 9541426A JP 54142697 A JP54142697 A JP 54142697A JP H11513891 A JPH11513891 A JP H11513891A
- Authority
- JP
- Japan
- Prior art keywords
- cell line
- dna
- smrv
- cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. リスザルレトロウイルスを含まないNamalwa細胞系。 2. サブタイプ2b、7、10、17および21を含んでなるα−インター フェロンサブタイプの個体群を産生することができる、請求項1に記載の細胞系 。 3. サブタイプが、サブタイプ1、2b、5、7、8、10、14、17お よび21を含んでなる、請求項2に記載の細胞系。 4. α−インターフェロンサブタイプが、下記の量で産生される、請求項3 に記載の細胞系。 5. 天然には、リスザルレトロウイルスを含まない、請求項1〜4のいずれ か1項に記載の細胞系。 6. 細胞系ECACC94120840またはECACC94120841 によって産生されるものと実質的に同じα−インターフェロンサブタイプの個体 群を産生することができる、請求項1に記載の細胞系。 7. サブタイプの個体群が、細胞系ECACC94120840またはEC ACC94120841によって産生されるものと実質的に同じである、請求項 6に記載の細胞系。 8. 細胞系ECACC94120840またはECACC94120841 、またはそれらから誘導される細胞系である、請求項1に記載の細胞系。 9. 目的とするポリペプチドをコードする外来の発現可能なDNA配列を固 定する、請求項1〜8のいずれか1項に記載の細胞系。 10. 複製シグナル、パッケージング配列および目的とする遺伝子を含んで なる相当するウイルスベクターをパッケージングするのに十分な発現可能なウイ ルス遺伝子を固定する、請求項1〜8のいずれか1項に記載の細胞系。 11. α−インターフェロンの製造法であって、請求項1〜8のいずれか1 項に記載の細胞系を培養し、このようにして産生されたα−インターフェロンを 単離することを特徴とする、方法。 12. 請求項11に記載の方法によって産生されたα−インターフェロンを 、薬学上許容可能なそのキャリヤーと混合して含んでなる、医薬処方物。 13. 請求項1〜8のいずれか1項に記載の細胞系を、目的とするポリペプ チドをコードする発現可能なDNA配列でトランスフェクションすることを含ん でなる、請求項9に記載の細胞系の製造法。 14. 目的とするポリペプチドの製造法であって、請求項9に記載の細胞系 を、上記ポリペプチドが発現される条件下に保持し、発現したポリペプチドを回 収することを特徴とする、方法。 15. 請求項1〜8のいずれか1項に記載の細胞系を、複製シグナル、パッ ケージング配列および目的とする遺伝子を含んでなる相当するウイルスベクター をパッケージングするのに十分な発現可能なウイルス遺伝子でトランスフェクシ ョンすることを含んでなる、請求項10に記載の細胞系の製造法。 16. ウイルスのパッケージング法であって、請求項10に記載の細胞系を 、複製シグナル、パッケージング配列および目的とする遺伝子を含んでなる相当 す るウイルスベクターでトランスフェクションすることを含んでなる、方法。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1996/002185 WO1997044440A1 (en) | 1996-05-22 | 1996-05-22 | Cell line |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11513891A true JPH11513891A (ja) | 1999-11-30 |
JP3249134B2 JP3249134B2 (ja) | 2002-01-21 |
Family
ID=8166225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54142697A Expired - Lifetime JP3249134B2 (ja) | 1996-05-22 | 1996-05-22 | 細胞系 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0904352B1 (ja) |
JP (1) | JP3249134B2 (ja) |
AT (1) | ATE366802T1 (ja) |
DE (1) | DE69637159T2 (ja) |
DK (1) | DK0904352T3 (ja) |
ES (1) | ES2288755T3 (ja) |
PT (1) | PT904352E (ja) |
WO (1) | WO1997044440A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001226287A (ja) * | 2000-02-17 | 2001-08-21 | Sumitomo Pharmaceut Co Ltd | 安定な注射用製剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074808A3 (en) * | 1981-09-16 | 1984-07-04 | University Patents, Inc. | Recombinant method and materials |
WO1993000103A1 (en) * | 1991-06-21 | 1993-01-07 | The Wistar Institute Of Anatomy And Biology | Chimeric envelope proteins for viral targeting |
-
1996
- 1996-05-22 WO PCT/EP1996/002185 patent/WO1997044440A1/en active IP Right Grant
- 1996-05-22 PT PT96919794T patent/PT904352E/pt unknown
- 1996-05-22 DE DE69637159T patent/DE69637159T2/de not_active Expired - Lifetime
- 1996-05-22 JP JP54142697A patent/JP3249134B2/ja not_active Expired - Lifetime
- 1996-05-22 ES ES96919794T patent/ES2288755T3/es not_active Expired - Lifetime
- 1996-05-22 DK DK96919794T patent/DK0904352T3/da active
- 1996-05-22 AT AT96919794T patent/ATE366802T1/de active
- 1996-05-22 EP EP96919794A patent/EP0904352B1/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001226287A (ja) * | 2000-02-17 | 2001-08-21 | Sumitomo Pharmaceut Co Ltd | 安定な注射用製剤 |
JP4536194B2 (ja) * | 2000-02-17 | 2010-09-01 | 大日本住友製薬株式会社 | 安定な注射用製剤 |
Also Published As
Publication number | Publication date |
---|---|
ATE366802T1 (de) | 2007-08-15 |
PT904352E (pt) | 2007-10-01 |
EP0904352B1 (en) | 2007-07-11 |
DE69637159T2 (de) | 2008-03-20 |
WO1997044440A1 (en) | 1997-11-27 |
DK0904352T3 (da) | 2007-10-29 |
DE69637159D1 (de) | 2007-08-23 |
JP3249134B2 (ja) | 2002-01-21 |
EP0904352A1 (en) | 1999-03-31 |
ES2288755T3 (es) | 2008-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Accola et al. | A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly | |
Yoshida et al. | Recent advances in the molecular biology of HTLV-1: trans-activation of viral and cellular genes | |
Chu et al. | SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen | |
de la Torre et al. | Establishment of cell lines persistently infected with foot-and-mouth disease virus | |
Feigenbaum et al. | Regulation of the host range of human papovavirus JCV. | |
Andersson et al. | A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection | |
JP2007082562A (ja) | 医薬的および診断的使用のための組み換えフオーミーウイルスベクター、および組み換えフオーミーウイルスベクターの作製方法 | |
Roberts et al. | Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression | |
JP2633510B2 (ja) | 動物インターフェロン | |
WO1996021036A2 (en) | Nucleic acid condensing agents with reduced immunogenicity | |
Green et al. | Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation | |
KR20160102024A (ko) | 아데노바이러스 및 상응하는 플라스미드의 제조 방법 | |
CN112442514B (zh) | 慢病毒包装载体系统、慢病毒及其构建方法、试剂盒 | |
CN114941011A (zh) | 慢病毒载体及其应用 | |
JPH11500905A (ja) | 増幅配列、これらの配列を有するベクター、およびトランスフェクションされた細胞においてヌクレオチド配列を発現させるための組成物、治療用およびワクチン用におけるこれらの使用 | |
US4939088A (en) | Sustained production of recombinant gamma interferon using an Epstein-Barr virus replicon | |
JP3249134B2 (ja) | 細胞系 | |
CN114107176A (zh) | 一种稳定表达非洲猪瘟CD2v蛋白的CHO细胞系及其构建方法和应用 | |
CA1309044C (en) | Method of producing foreign gene products | |
US5821080A (en) | Cell line | |
EP0917585B1 (en) | Vectors for delivering viral and oncogenic inhibitors | |
JP3449418B2 (ja) | 内因性レトロウイルス様配列内への遺伝子標的化による発現の増大 | |
AU604791B2 (en) | Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained | |
Fuchs | Quality control of biotechnology-derived vaccines: technical and regulatory considerations | |
JP4676063B2 (ja) | 弱毒水痘ウイルス岡株の遺伝子62とこの遺伝子62を用いる弱毒生水痘ワクチン用ウイルス株の同定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071109 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081109 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091109 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101109 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111109 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121109 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121109 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131109 Year of fee payment: 12 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |